Sahin et al. [72] reported that protein coded by CLDN18 splice variant 2, termed CLDN18.2, is present in several cancers including gastric (77% positive), pancreatic (80% positive), and esophageal (78% positive) cancers. The gene discussed is CLDN18; the disease is cancer.